Ac225-DOTA-M5A

Actinium-225 labeled anti-CEA antibody M5A · City of Hope Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ac225-DOTA-M5A, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers [Phase 1]

See pricing